BIBLIOMETRIC ANALYSIS OF GLOBAL RESEARCH TRENDS IN MYOPIA PROGRESSION (2000–2025)
Main Article Content
Keywords
Myopia progression, axial length, atropine, orthokeratology, outdoor time, bibliometric analysis
Abstract
Background: Myopia progression is now a global concern. The issue is most visible in East and Southeast Asia, where rates in schoolchildren have reached epidemic levels. This paper examines worldwide publication trends in myopia progression between 2000 and 2025.
Methods: We searched Scopus and Web of Science in January 2025 for studies published from 2000 to 2024. Search terms included myopia progression, axial length, childhood myopia, and juvenile myopia. After screening, 5,962 papers were analyzed. We looked at annual growth, country and institutional output, journal distribution, citations, and keyword patterns.
Results: The literature grew more than six-fold, with the sharpest surge after 2010. China, the United States, and Japan were the largest contributors, followed by Singapore, South Korea, and Australia. Institutions such as Sun Yat-sen University, the National University of Singapore, and The University of Hong Kong produced the most work. Early research mainly described prevalence and risk factors, while later studies turned to control methods, orthokeratology, low-dose atropine, and outdoor-time strategies.
Conclusion: Research on myopia progression has expanded rapidly. Asia leads output, but stronger global partnerships are needed if the rising burden of myopia is to be effectively addressed.
References
[2] Ohno-Matsui K, Wu PC, Yamashiro K, Vutipongsatorn K, Fang Y, Cheung CMG, et al. IMI Pathologic Myopia. Invest Ophthalmol Vis Sci 2021;62(5):5.
[3] Morgan IG, Ohno-Matsui K, Saw SM. Myopia. Lancet 2012;379(9827):1739–48.
[4] Wu PC, Huang HM, Yu HJ, Fang PC, Chen CT. Epidemiology of myopia. Asia Pac J Ophthalmol (Phila) 2016;5(6):386–93.
[5] Chia A, Chua WH, Cheung YB, Wong WL, Lingham A, Fong A, et al. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses. Ophthalmology 2012;119(2):347–54.
[6] Walline JJ, Greiner KL, McVey ME, Jones-Jordan LA. Multifocal contact lens myopia control. Optom Vis Sci 2013;90(11):1207–14.
[7] Xiong S, Sankaridurg P, Naduvilath T, Zang J, Zou H, Zhu J, et al. Time spent in outdoor activities in relation to myopia prevention and control: a meta-analysis and systematic review. Acta Ophthalmol 2017;95(6):551–66.
[8] van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics 2010;84(2):523–38.
[9] Yang F, Zhou X, Ma J, Li M, Zhang H. Bibliometric and visualized analysis of myopic corneal refractive surgery: from 1979 to 2022. Front Med 2023;10:1141438.
[10] Sweileh WM. Bibliometric analysis of global scientific literature on glaucoma. Eye (Lond) 2017;31(7):1119–28.
[11] Shan M, Dong Y, Chen J, Su Q, Wang Y. Global tendency and frontiers of research on myopia from 1900 to 2020: a bibliometrics analysis. Front Public Health 2022;10:846601.
[12] Yang J, Zhang Q, Cao D, Li J, Lv H, Wang Y. Global trends and frontiers of research on pathologic myopia: a bibliometric and visualization study. Front Public Health 2022;10:1047787.
[13] Pan CW, Ramamurthy D, Saw SM. Worldwide prevalence and risk factors for myopia. Ophthalmic Physiol Opt 2012;32(1):3–16.
[14] Cho P, Tan Q. Retardation of myopia in Orthokeratology (ROMIO) study: a 2-year randomized clinical trial. Invest Ophthalmol Vis Sci 2012;53(11):7077–85.
[15] Yam JC, Jiang Y, Tang SM, Law AK, Chan JJ, Wong E, et al. Low-concentration atropine for myopia progression (LAMP) study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control. Ophthalmology 2019;126(1):91–101.
[16] He M, Xiang F, Zeng Y, Mai J, Chen Q, Zhang J, et al. Effect of time spent outdoors at school on the development of myopia among children in China: a randomized clinical trial. JAMA 2015;314(11):1142–8.
[17] Zhang Y, Huang X, Li J, Xu X, Ding Y. Bibliometric analysis of research trends on myopia from 2000 to 2020. BMC Ophthalmol 2021;21(1):403.
[18] Sweileh WM. A bibliometric analysis of global research output on health and human rights (1990–2020). Glob Health Res Policy 2021;6(1):5.